{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:40:07Z","timestamp":1773916807394,"version":"3.50.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Urol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Prostate biopsy is the reference standard for confirming prostate cancer in men with clinical suspicion. The transrectal (TR) route is widely used but carries a risk of infectious complications and may sample anterior regions less effectively. Transperineal (TP) biopsy has emerged as a safer alternative with lower infectious risk. However, real-world comparative evidence between the routes is limited in some settings. The objective is to compare the diagnostic yield, tissue quality, and complications of systematic TR versus TP prostate biopsy in a Moroccan tertiary center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective study, 139 men with suspected prostate cancer underwent systematic biopsy via TR or TP biopsy. Analyses were restricted to systematic cores. Biopsy quality was assessed by median core length. Complications were graded using the Clavien\u2013Dindo classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 139 men underwent systematic biopsy. Baseline clinical characteristics were similar across most variables, except DRE, between groups. TP yielded a longer median core length than TR (p = 0.02). In contrast, detection rates of clinically significant prostate cancer (csPCa) were similar (40.3% for TR vs 38.9% for TP). Several clinical factors were associated with csPCa detection, including higher PSA, higher PSA density, suspicious DRE, and higher PI-RADS category. In contrast, anterior lesion location was associated with a lower risk of csPCa. Regarding complications, infectious complications were more common after TR biopsy (7.5% compared to 1.4%). Additionally, acute urinary retention was seen in 6.0% of TR cases and 8.3% of TP cases. No Clavien\u2013Dindo grade III or higher events were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TP systematic biopsy provides csPCa detection comparable to TR biopsy, yields longer cores, and shows a lower observed rate of infectious complications, supporting TP adoption to reduce infectious morbidity without compromising diagnostic performance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fruro.2026.1806961","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:23:34Z","timestamp":1773897814000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Transperineal versus transrectal systematic prostate biopsy in routine clinical practice: a real-world comparative study"],"prefix":"10.3389","volume":"6","author":[{"given":"Anouar","family":"El Ghazzaly","sequence":"first","affiliation":[{"name":"Department of Urology, Mohamad V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Mrabeti","sequence":"additional","affiliation":[{"name":"Department of Urology, Mohamad V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdesamad","family":"El Bahri","sequence":"additional","affiliation":[{"name":"Department of Urology, Mohamad V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larbi","family":"Hamedoun","sequence":"additional","affiliation":[{"name":"Department of Urology, Mohamad V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Tetou","sequence":"additional","affiliation":[{"name":"Department of Urology, Mohamad V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Alami","sequence":"additional","affiliation":[{"name":"Department of Urology, Mohamad V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ameur","sequence":"additional","affiliation":[{"name":"Department of Urology, Mohamad V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.12.015","article-title":"Transperineal Versus Transrectal Magnetic Resonance Imaging\u2013targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial","volume":"86","author":"Hu","year":"2024","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003788","article-title":"Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial","volume":"211","author":"Mian","year":"2024","journal-title":"J Urol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003979","article-title":"Clinically Significant Prostate Cancer Detection Following Transrectal and Transperineal Biopsy: Results of the Prostate Biopsy Efficacy and Complications Randomized Clinical Trial","volume":"212","author":"Mian","year":"2024","journal-title":"J Urol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00100-7","article-title":"Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial","volume":"26","author":"Bryant","year":"2025","journal-title":"Lancet Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-019-1573-0","article-title":"Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Xiang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)38508-7","article-title":"Determination of Prostate Volume by Transrectal Ultrasound","volume":"145","author":"Terris","year":"1991","journal-title":"J Urol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.01.019","article-title":"Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1)","author":"Ploussard","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2023.09.013","article-title":"Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE)","volume":"7","author":"Klotz","year":"","journal-title":"Eur Urol Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.prnil.2023.08.002","article-title":"Detection of anterior prostate cancer using a magnetic resonance imaging-transrectal ultrasound fusion biopsy in cases with initial biopsy and history of systematic biopsies","volume":"11","author":"Abe","year":"2023","journal-title":"Prostate Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2025.07.005","article-title":"Infectious Complications After Transrectal Versus Transperineal Prostate Biopsy: A Systematic Review and Meta-analysis","author":"Stangl","year":"2025","journal-title":"Eur Urol Focus"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.07.009","article-title":"Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy: A Systematic Review and Meta-analysis of Prospective Studies","volume":"7","author":"Zattoni","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-23101-z","article-title":"Accuracy and safety of in-office transperineal freehand cognitive fusion prostate biopsy under local anaesthesia without antibiotic prophylaxis","volume":"15","author":"Lenart","year":"2025","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14124377","article-title":"Transperineal Prostate Biopsy Under Local Anaesthesia, Tolerability, and Functional Outcomes: A Prospective, Monocentric, and Single-Operator Study","volume":"14","author":"Adans-Dester","year":"2025","journal-title":"J Clin Med"}],"container-title":["Frontiers in Urology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fruro.2026.1806961\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:23:35Z","timestamp":1773897815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fruro.2026.1806961\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":19,"alternative-id":["10.3389\/fruro.2026.1806961"],"URL":"https:\/\/doi.org\/10.3389\/fruro.2026.1806961","relation":{},"ISSN":["2673-9828"],"issn-type":[{"value":"2673-9828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"article-number":"1806961"}}